Fibrogen(FGEN)发布Q3财报，2024财年前三财季累计收入1.53亿美元，去年同期累计收入为1.21亿美元，同比增长26.75%。 2024财年前三财季累计净亏损6556.10万美元，去年同期累计净亏损为2.28亿美元，同比缩小71.25%。 本财年累计基本每股收益为-0.66美元，去年同期为-2.35美元。 公司所属行业为生物科技。 Fibrogen, Inc.于1993年在美国特拉 ...

What the researchers found was compelling: notochord cells secrete connective tissue growth factor (CTGF)--a recently characterized protein with multifunctional anabolic properties. CTGF gene ...

They were the last throw of the dice for pamrevlumab, which has been vying to become the first therapy targeting connective tissue growth factor (CTGF) to come to market. The drug was earlier ...

Loomis Sayles Growth recently changed its parameters on individual position sizes. The move acknowledges the evolving makeup of the strategy’s S&P 500 prospectus benchmark—and the Russell 1000 ...

Fat culturing remains a challenging task in the process of producing optimal cultivated meat. Here, using antibiotic-free culture conditions, the authors establish bovine adipose-derived stem cell ...

The top-line results revealed that pamrevlumab, which targets connective tissue growth factor, failed to produce an improvement compared with placebo, measured against an endpoint of change from ...

× Zoomable Statistic: Select the range in the chart you want to zoom in on.

Growth stocks are made up of companies that are set to grow their earnings and revenue by an abundant amount compared to the rest of the market, which also has an impact on the price of each ...

Editorial Note: Blueprint may earn a commission from affiliate partner links featured here on our site. This commission does not influence our editors' opinions or evaluations. Please view our ...

I saw a ad on Wal-mart to lose weight and get good bacteria in a pill to take 2 times a day called ProbioSlim for only 2.99 to lose weight all in one pill. The ad did not say Force Factor would ...

J.B. Maverick is an active trader, commodity futures broker, and stock market analyst 17+ years of experience, in addition to 10+ years of experience as a finance writer and book editor. Dr ...